News & Events
 
 

Archives
 

Hepatitis B and C – Preventable Global Killers

 

Pakistan is an endemic country for both hepatitis B and C. Roughly seven million Pakistanis, or 5 % of the population, are carriers of hepatitis B and the figure for hepatitis C is even larger. These findings were disclosed by Dr S. M. Wasim Jafri, Professor and Chief of Gastroenterology and Chairman, Department of Medicine at Aga Khan University, during a 'Signs, Symptoms, and Care' health awareness programme held at Aga Khan University Hospital (AKUH) Clifton Medical Services on Thursday, September 23, 2004. "This alarming spread is putting enormous pressure on an already resource-strapped health care system," he said.

Dr Jafri attributed the rising incidence of hepatitis B and C to poor awareness, lack of basic health care and below-par screening facilities. In particular, he pointed to the multiple use of disposable needles and syringes, substandard transfusion services, quackery and poor dental health care.

He stressed the critical importance of vaccination against hepatitis B and said that vaccinating all newborns on the day of birth would result in a substantial drop in incidence over the next decade. "This would also control mother-to-infant transmission of hepatitis B, which occurs at the time of birth or just thereafter," said Dr Jafri. "Ninety-five per cent of infants who acquire infection very early in life become chronic carriers of hepatitis B and may suffer from chronic liver disease and hepatocellular carcinoma in adolescence. However, less than 10 % of patients become carriers if the infection is acquired in adult life." In adults, the vaccine should be offered to people at high risk, such as health care workers, phlebotomists, dentists, paramedics and nurses," he added.

Elaborating on the current management of hepatitis C, Dr Jafri maintained that if the disease is detected in time, chances of effecting a cure with the currently available treatment, which is based on Interferon and Ribavarin, stand at almost 80 to 90%. This treatment is, however, expensive. "But the disease cannot be cured if it progresses to the cirrhotic stage, and emphasis should therefore be placed on timely diagnosis of the disease."

Commenting on the treatment of hepatitis B and C in Pakistan, he said that treatment available in the country is at par with the rest of the world. He concluded by urging the government and NGOs to work together to control the spread of hepatitis B and C in Pakistan.

 

 

 News
School of Nursing Hospitals Medical College Institute for the Study of Muslim Civilisations Institute for Educational Development Examination Board  Home Site Map Contact Us